1. Home
  2. Live Updates
  3. Henoch schönlein purpura

Live Breaking News & Updates on Henoch schönlein purpura

Stay informed with the latest breaking news from Henoch schönlein purpura on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Henoch schönlein purpura and stay connected to the pulse of your community

Fauci Unmoved by One-Dose COVID Vax Studies


email article
Despite recent media hype over the supposed effectiveness of one dose of the Moderna and Pfizer/BioNTech COVID-19 vaccines, the FDA and government scientists aren't budging from the two-dose approach, officials said at a press briefing on Friday.
Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, argued that one dose doesn't assure a durable immune response, and thus leaves potential for people with poorer immune responses to become incubators for escape variants.
Commenting largely about an Israeli study published in
The Lancet, which appeared to show that one dose of the Pfizer/BioNTech vaccine is 85% effective, Fauci called the results "interesting," but added, "we will stick with the scientifically documented efficacy and optimal response of a prime followed by a boost" of mRNA vaccine.

White-house , District-of-columbia , United-states , Israel , Israeli , Andy-slavitt , Molly-walker , Rochelle-walensky , Anthony-fauci , Fedex , National-institute-of-allergy , National-institute

Feds Say More COVID Vax Doses on the Way; Variants Not a Worry (Yet)


email article
WASHINGTON -- Biden administration officials sought to assure the public Wednesday that COVID-19 vaccine shipments will increase soon, and that current vaccines should be able to accommodate most of the variants that have arisen.
"When you're looking at the U.K. variant, what we're seeing is very slight -- if any impact -- on vaccine-induced antibodies and very little impact on anything else, so we're covered with that," Anthony Fauci, MD, director of the National Institute on Allergy and Infectious Diseases and President Biden's chief medical advisor, said during an online reporter briefing.
"Things get a bit more problematic ... with what we're seeing on the dominant one in South Africa," he continued. "In that regard, there is a moderate diminution -- namely a multi-fold diminution -- in the

White-house , District-of-columbia , United-states , South-africa , South-african , Andy-slavitt , Marcella-nunez-smith , Joyce-frieden , Rochelle-walensky , Anthony-fauci , Pfizer , Supreme-court

CDC: Anaphylaxis Rate With COVID Vax 10 Times Greater Than for Flu Shots

But events still rare and nonfatal, and benefits outweigh risks, officials say

Molly-walker , Nancy-messonnier , Pfizer , National-center , Mortality-weekly-report , Respiratory-diseases , Mortality-weekly , Henoch-schönlein-purpura , Anaphylaxis , Shock , Hypersensitivity-reaction